Immediate Impact
17 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Liver diseases: epidemiology, causes, trends and predictions
2025 Standout
Works of Ming-Jong Bair being referenced
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ming-Jong Bair | 15 | 15 | 4 | 19 | 18 | 4 | 48 | |
| Yvonne Schmiedel | 17 | 4 | 10 | 11 | 25 | 5 | 65 | |
| Beatrice Nassanga | 8 | 2 | 3 | 21 | 14 | 5 | 84 | |
| Diego Maseda | 25 | 3 | 8 | 12 | 5 | 48 | ||
| L A Kudyakov | 5 | 3 | 10 | 14 | 3 | 5 | 51 | |
| L. Jones | 33 | 27 | 3 | 2 | 19 | 5 | 75 | |
| Hayford Howard | 30 | 5 | 10 | 11 | 5 | 48 | ||
| Milly Namutebi | 5 | 1 | 2 | 14 | 14 | 4 | 71 | |
| Khadija Said Mohammed | 16 | 9 | 12 | 34 | 7 | 50 | ||
| Claudia M. M. Abrahim | 4 | 3 | 14 | 29 | 5 | 38 | ||
| C. Medrano | 4 | 11 | 10 | 18 | 5 | 39 |
All Works
Loading papers...